Wolinsky JS - Search Results

1

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. Among authors: wolinsky js. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.

2

Proton magnetic resonance spectroscopy in multiple sclerosis.

Wolinsky JS, Narayana PA, Fenstermacher MJ. Wolinsky JS, et al. Neurology. 1990 Nov;40(11):1764-9. doi: 10.1212/wnl.40.11.1764. Neurology. 1990. PMID: 2172865

3

Effect of cyclosporine on rubella virus-specific immune responses in chronic progressive multiple sclerosis.

Nath A, Wolinsky JS, Kerman RH. Nath A, et al. Among authors: wolinsky js. J Neuroimmunol. 1989 Apr;22(2):143-8. doi: 10.1016/0165-5728(89)90045-3. J Neuroimmunol. 1989. PMID: 2925842 Clinical Trial.

4

Serial immune evaluation of cyclosporine- and placebo-treated multiple sclerosis patients.

Kerman RH, Wolinsky JS, Nath A, Sears ES Jr. Kerman RH, et al. Among authors: wolinsky js. J Neuroimmunol. 1988 Jul;18(4):325-31. doi: 10.1016/0165-5728(88)90053-7. J Neuroimmunol. 1988. PMID: 2968363 Clinical Trial.

5

Multiple sclerosis: clinical presentation, diagnosis and treatment.

Brod SA, Lindsey JW, Wolinsky JS. Brod SA, et al. Among authors: wolinsky js. Am Fam Physician. 1996 Sep 15;54(4):1301-6, 1309-11. Am Fam Physician. 1996. PMID: 8816574 Review.

6

Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis. The MS Study Group.

Zhao GJ, Li DK, Wolinsky JS, Koopmans RA, Mietlowski W, Redekop WK, Riddehough A, Cover K, Paty DW. Zhao GJ, et al. Among authors: wolinsky js. J Neuroimaging. 1997 Jan;7(1):1-7. doi: 10.1111/jon1997711. J Neuroimaging. 1997. PMID: 9038425 Clinical Trial.

7

T cell-T cell activation in multiple sclerosis.

Lindsey JW, Kerman RH, Wolinsky JS. Lindsey JW, et al. Among authors: wolinsky js. Mult Scler. 1997 Aug;3(4):238-42. doi: 10.1177/135245859700300404. Mult Scler. 1997. PMID: 9372506

8

The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis.

Arnold DL, Wolinsky JS, Matthews PM, Falini A. Arnold DL, et al. Among authors: wolinsky js. J Neurol Neurosurg Psychiatry. 1998 May;64 Suppl 1:S94-101. J Neurol Neurosurg Psychiatry. 1998. PMID: 9647294 Free article. Review.

9

Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.

Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, Arnold DL. Matthews PM, et al. Among authors: wolinsky js. Semin Neurol. 1998;18(3):327-36. doi: 10.1055/s-2008-1040884. Semin Neurol. 1998. PMID: 9817537 Review.

10

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials. National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Goodkin DE, Reingold S, Sibley W, Wolinsky J, McFarland H, Cookfair D, Lublin F. Goodkin DE, et al. Ann Neurol. 1999 Jul;46(1):132-4. doi: 10.1002/1531-8249(199907)46:1<132::aid-ana22>3.0.co;2-z. Ann Neurol. 1999. PMID: 10401793 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page